Abstract:Regulatory T (Treg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses1,2,3,4. Foxp3 operates as a late-acting differentiation factor controlling Treg cell homeostasis and function5, whereas the early Treg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors6,7,8,9,10. However, whether Foxo proteins act beyond the Treg-cell-commitment stage to control Treg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of Tregcell function. Treg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with Treg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of Treg cells. Genome-wide analysis of Foxo1 binding sites reveals ∼300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt–Foxo1 signalling module controls a novel genetic program indispensable for Treg cell function. The results of a series of genetic experiments indicate that Foxo1 has a pivotal, Foxp3-independent role controlling regulatory T-cell function. Foxo transcription factors are known to be involved in the control of immune homeostasis at least up to the regulatory T (Treg)-cell commitment stage. This paper reveals a crucial role for Foxo1 in the control of Treg-cell-dependent immune tolerance, independent of Foxo3. The authors propose that Treg cells co-opt the evolutionarily ancient Akt–Foxo1 signalling pathway to control a novel genetic program essential for Treg-cell function. This raises the possibility that manipulating the Akt–Foxo1 signalling pathway might offer a treatment for Treg-cell-associated immunological disorders.

Foxo1 Promotes Th9 Cell Differentiation and Airway Allergy

Transcription factor Foxo1 is essential for IL-9 induction in T helper cells

Transcriptional Control of Th9 Cells: Role of Foxo1 in Interleukin-9 Induction

Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7

Foxp2 inhibits Th9 cell differentiation and attenuates allergic airway inflammation in a mouse model of ovalbumin-induced asthma

Th9 cell development requires a BATF-regulated transcriptional network

FoxO1 regulates allergic asthmatic inflammation through regulating polarization of the macrophage inflammatory phenotype.

FoxO1 suppresses IL-10 producing B cell differentiation via negatively regulating Blimp-1 expression and contributes to allergic asthma progression

Foxo1 drives the TGFβ1-dependent dichotomy of Th17 cell fates

The Pioneer Transcription Factor Foxa2 Modulates T Helper Differentiation to Reduce Mouse Allergic Airway Disease

MiR-493-5p inhibits Th9 cell differentiation in allergic asthma by targeting FOXO1

Enhanced Local Foxp3 Expression in Lung Tissue Attenuates Airway Inflammation in A Mouse Model of Asthma

OX40 signaling favors the induction of T H 9 cells and airway inflammation

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

Nitric oxide enhances Th9 cell differentiation and airway inflammation

Th9 Cells in Allergic Disease

Foxo3 Promotes the Differentiation and Function of Follicular Helper T Cells.

Th9 and other IL-9-producing cells in allergic asthma

Differentiation, Regulation and Function of Th9 Cells

The TNF-Family Ligand TL1A and Its Receptor DR3 Promote T Cell–Mediated Allergic Immunopathology by Enhancing Differentiation and Pathogenicity of IL-9–Producing T Cells

The FoxO4/DKK3 axis represses IFN-gamma expression by Th1 cells and limits antimicrobial immunity